Flower City Capital

Position in KURA — Kura Oncology, Inc.

CIK 1808394 PITTSFORD, NY

Position in KURA

as of Mar 31, 2026 · filed Apr 14, 2026 Compact

Position Value

$146,340

+$21,660 QoQ

Shares Held

18,000

+50.0% QoQ

Ownership

0.020%

of shares outstanding

% of Portfolio

1.15%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2025

5 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Flower City Capital holds $517,862 across 4 Biotechnology names. KURA ranks #2 (28.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IMRX	Immuneering Corp	55,029	$290,002
2	KURA	Kura Oncology, Inc. This page	18,000	$146,340
3	PGEN	Precigen, Inc.	20,000	$77,400
4	OTLK	Outlook Therapeutics, Inc.	20,000	$4,120

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$146,340	18,000	+50.0%	Shares	Sole	2026-04-14
2025-12-31	$124,680	12,000	+20.0%	Shares	Sole	2026-01-22
2025-09-30	$88,500	10,000	0.0%	Shares	Sole	2025-10-08
2025-06-30	$57,700	10,000	-16.7%	Shares	Sole	2025-07-16
2025-03-31	$79,200	12,000	—	Shares	Sole	2025-04-22
No filing history on record for this holder in this stock.